Jean-François Pujol
Chief Tech/Sci/R&D Officer at Biocortech SAS
Profile
Jean-François Pujol co-founded Biocortech AS and serves as Chief Scientific Officer.
He is a Professor at the Laennec Medical School.
Previously, he was Head of CNS Department for Roussel Uclaf (now Sanofi-Aventis).
He has been a Member of the Board of Directors at University of Lyon, the Neuroscience Fed Institute, Liège Cyclotron.
Dr. Pujol received an MD and a PhD from the Lyon University.
Jean-François Pujol active positions
| Companies | Position | Start |
|---|---|---|
Biocortech SAS
 Biocortech SAS Pharmaceuticals: MajorHealth Technology Biocortech SAS discovers and develops drug therapies for brain disorders. The company is engaged in treating pathologies and focuses its R&D program on depression, schizophrenia and cognitive deficits. Biocortech develops pharmaceuticals for deficient pathways in the adult brain or deficient receptors via the modulation of RNA editing mechanisms. The company was founded by Dinah Weissmann in 2001 and is headquartered in Paris, France. | Chief Tech/Sci/R&D Officer | - |
Former positions of Jean-François Pujol
| Companies | Position | End |
|---|---|---|
| University of Lyon | Corporate Officer/Principal | - |
| Roussel Uclaf SA | Corporate Officer/Principal | - |
Training of Jean-François Pujol
| Ecole Centrale Lyon | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Biocortech SAS
Biocortech SAS Pharmaceuticals: MajorHealth Technology Biocortech SAS discovers and develops drug therapies for brain disorders. The company is engaged in treating pathologies and focuses its R&D program on depression, schizophrenia and cognitive deficits. Biocortech develops pharmaceuticals for deficient pathways in the adult brain or deficient receptors via the modulation of RNA editing mechanisms. The company was founded by Dinah Weissmann in 2001 and is headquartered in Paris, France. | Health Technology |
| Roussel Uclaf SA | Health Technology |
- Stock Market
- Insiders
- Jean-François Pujol
